EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, AVCNF: Avicanna Inc

23 Oct 2025
LAST:

0.1871

CHANGE:
 0.00		OPEN:
0.1779		HIGH:
0.1871		ASK:
0.0000		VOLUME:
21.7K
CHG(%):
1.53		PREV:
0.1900		LOW:
0.1779		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Oct 250.17790.18710.17790.187121.7K
20 Oct 250.19000.19000.18320.1900300
17 Oct 250.19030.19030.19030.19035.8K
16 Oct 250.19300.20760.19300.20766.9K
15 Oct 250.19910.20420.18370.200084.2K
14 Oct 250.20000.20000.20000.200050.0K
13 Oct 250.19500.22280.19500.218040.0K
10 Oct 250.20050.20400.19050.1905113.5K
09 Oct 250.19080.19910.18720.1985285.7K
08 Oct 250.18650.18650.18650.186514.5K

COMPANY PROFILE

Name:Avicanna Inc
About:Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizure associated with Lennox-Gastaut Syndrome and Dravet Syndrome. The company also offers active pharmaceutical ingredients comprising various cannabidiol, tetrahydrocannabinol, and cannabigerol flower for use in the development and production of food, cosmetics, medical, and pharmaceutical products under the Aureus Santa Marta brand. In addition, it operates MyMedi.ca, a medical cannabis care platform that offers a diverse portfolio of products and bilingual pharmacist-led patient support programs, specialty services to veterans, as well as provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens; and collaborates with public and private payers for adjudication and reimbursement. The company has a research and collaboration agreement with a multinational European based pharmaceutical company to assess its proprietary SEDDS technology in combination with Collaborator's various drug delivery and pharmaceutical formats. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.
Sector:Healthcare
Address:480 University Avenue, Toronto, ON, Canada, M5G 1V2
Website:https://www.avicanna.com
CIK:0001811059
FIGI:BBG00Q392GP4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.204.2%
MA10:0.205.2%
MA20:0.191.1%
MA50:0.204.3%
MA100:0.193.6%
MA200:0.205.8%
STO14:11.85 
RSI14:52.66
WPR14:-86.55 
MTM14:0.00
ROC14:0.03 
ATR:0.01 
Week High:0.2111.0%
Week Low:0.185.2%
Month High:0.2219.1%
Month Low:0.175.8%
Year High:0.2851.0%
Year Low:0.1262.7%
Volatility:12.08